ウクライナの医薬品市場

【英語タイトル】Generic and innovative drugs market in Ukraine 2014.
Development forecasts for 2014-2019.

PMRが出版した調査資料(PMR41107)・商品コード:PMR41107
・発行会社(調査会社):PMR
・発行日:2014年8月
・ページ数:100
・レポート言語:英語
・レポート形式:pdf
・納品方法:Eメール
・調査対象地域:ウクライナ
・産業分野:製薬
◆販売価格オプション(消費税別)
Single userEUR950 ⇒換算¥126,350見積依頼/購入/質問フォーム
Five UserEUR1,425 ⇒換算¥189,525見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日~2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

Explore key issues on the Ukrainian market for generic and innovative drugs.
Report forecasts market development, analyses regulatory changes to 2019.

Which are the most influential manufacturers of generic and innovative drugs for the Ukrainian market? What reimbursement policies will most likely influence this market in the near future? Which data exclusivity rules apply to the Ukrainian market for generic and innovative drugs? What is the current and forecast value of this market and its major segments? What are the forecasts for market conditions in Ukraine over the next six years?
Generic and innovative drugs market in Ukraine, development forecasts for 2014-2019 answers these questions along with many others. This publication, compiled by PMR’s team of experienced professionals, offers business information for use in a variety of vital tasks, from evaluating growth prospects to building a more attractive product portfolio.
The report examines changes in the value of the market and major segments from 2009-2014, studies the market share of the Ukrainian pharmaceuticals market currently held by generic and innovative medicines and provides in depth forecasts for market growth and transformation in the years ahead.
The document scrutinises regulations that currently govern pricing and reimbursement of generic and innovative drugs in Ukraine, supplies VAT rates and describes the changes expected with regard to the establishment of the system of the reimbursement. It provides descriptions of the data exclusivity and patent expiration rules and offers analyses of the results of recent changes to industry regulations.
Profiles of top generic and innovative drug producers in Ukraine describe the size, earnings and prospects for each company. Best selling products in each category are named, and patient and physician preferences with regard to generic and innovative medicines are supplied.
Whether businesspeople involved in this industry need to review market regulations particular to Ukraine, check on reimbursement procedures and upcoming changes or estimate demand or growth potential of this market – they will find the informational support needed in this valuable document. It is a remarkable asset when taking business decisions with implications that reach far into the future, such as whether to launch a new business or add a new product line.
Generic and innovative drugs market in Ukraine, development forecasts for 2014-2019 is typically utilised by businesses assessing the market for possible entry, current producers and distributors of generic and innovative drugs for the Ukrainian market and a variety of investment and financial service professionals. Research and consulting professionals also avail themselves of its advantages, along with academic and government institutions, trade and commerce-oriented organizations and business consultants.
Purchase this report today and enjoy the benefits of a complete source of business information, analysis and forecasts contained in a single, easy to access document. Convenient, reliable and logically organised, it is a true time (and money) saver. Order your copy now!

【レポートの目次】

Methodology 6
Executive summary 10
Characteristics of generic and innovative drugs markets in CIS countries 12
Generic and innovative drugs market in Ukraine 16
Profiles of key manufacturers 46
List of graphs 94
List of tables 96
About PMR 99



★調査レポート[ウクライナの医薬品市場] (コード:PMR41107)販売に関する免責事項を必ずご確認ください。
★調査レポート[ウクライナの医薬品市場]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆